Structural Basis of Antibody-Mediated Inhibition of Ricin Toxin Attachment to Host Cells.


Journal

Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623

Informations de publication

Date de publication:
21 Nov 2023
Historique:
medline: 23 11 2023
pubmed: 31 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

Monoclonal antibodies, JB4 and SylH3, neutralize ricin toxin (RT) by inhibiting the galactose-specific lectin activity of the B subunit of the toxin (RTB), which is required for cell attachment and entry. It is not immediately apparent how the antibodies accomplish this feat, considering that RTB consists of two globular domains (D1, D2) each divided into three homologous subdomains (α, β, γ) with the two functional galactosyl-specific carbohydrate recognition domains (CRDs) situated on opposite poles (subdomains 1α and 2γ). Here, we report the X-ray crystal structures of JB4 and SylH3 Fab fragments bound to RTB in the context of RT. The structures revealed that neither Fab obstructed nor induced detectable conformational alterations in subdomains 1α or 2γ. Rather, JB4 and SylH3 Fabs recognize nearly identical epitopes within an ancillary carbohydrate recognition pocket located in subdomain 1β. Despite limited amino acid sequence similarity between SylH3 and JB4 Fabs, each paratope inserts a Phe side chain from the heavy (H) chain complementarity determining region (CDR3) into the 1β CRD pocket, resulting in local aromatic stacking interactions that potentially mimic a ligand interaction. Reconciling the fact that stoichiometric amounts of SylH3 and JB4 are sufficient to disarm RTB's lectin activity without evidence of allostery, we propose that subdomain 1β functions as a "coreceptor" required to stabilize glycan interactions principally mediated by subdomains 1α and 2γ. Further investigation into subdomain 1β will yield fundamental insights into the large family of R-type lectins and open novel avenues for countermeasures aimed at preventing toxin uptake into vulnerable tissues and cells.

Identifiants

pubmed: 37903428
doi: 10.1021/acs.biochem.3c00480
doi:

Substances chimiques

Ricin 9009-86-3
Antibodies, Monoclonal 0
Epitopes 0
Toxins, Biological 0
Carbohydrates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3181-3187

Auteurs

David J Vance (DJ)

Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York 12208, United States.

Michael J Rudolph (MJ)

New York Structural Biology Center, New York, New York 10027, United States.

Simon A Davis (SA)

New York Structural Biology Center, New York, New York 10027, United States.

Nicholas J Mantis (NJ)

Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York 12208, United States.

Articles similaires

1.00
Immunoconjugates Humans Antibodies, Bispecific Receptor, ErbB-2 Cell Line, Tumor
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Antigen targeting and anti-tumor activity of a novel anti-CD146

Kim Lindland, Marion Masitsa Malenge, Ruth Gong Li et al.
1.00
Animals Humans CD146 Antigen Mice Immunoconjugates

Classifications MeSH